Welcome to LookChem.com Sign In|Join Free

CAS

  • or

444902-32-3

Post Buying Request

444902-32-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

444902-32-3 Usage

General Description

3-Pyridinamine, 6-chloro-5-iodo- is a chemical compound with the molecular formula C5H4ClIN2. It is a derivative of pyridine and contains both chlorine and iodine atoms. 3-PYRIDINAMINE, 6-CHLORO-5-IODO- is commonly used in organic synthesis and can be a building block for various pharmaceuticals and agrochemicals. Its unique structure and properties make it useful in the development of new drugs and other important chemical products. Additionally, it may also be used as a reagent in chemical reactions and as a research tool in academic laboratories.

Check Digit Verification of cas no

The CAS Registry Mumber 444902-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,4,9,0 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 444902-32:
(8*4)+(7*4)+(6*4)+(5*9)+(4*0)+(3*2)+(2*3)+(1*2)=143
143 % 10 = 3
So 444902-32-3 is a valid CAS Registry Number.

444902-32-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (720003)  5-Amino-2-chloro-3-iodopyridine  97%

  • 444902-32-3

  • 720003-1G

  • 1,125.54CNY

  • Detail

444902-32-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-chloro-5-iodopyridin-3-amine

1.2 Other means of identification

Product number -
Other names 6-chloro-5-iodo-3-pyridinamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:444902-32-3 SDS

444902-32-3Relevant articles and documents

Synthesis and in-vivo evaluation of [11C]p-PVP-MEMA as a PET radioligand for imaging nicotinic receptors

Dolle, Frederic,Langle, Sandrine,Roger, Gaelle,Fulton, Roger R.,Lagnel-De Bruin, Beatrice,Henderson, David J.,Hinnen, Francoise,Paine, Taliesha,Coster, Mark J.,Valette, Heric,Bottlaender, Michel,Kassiou, Michael

, p. 438 - 445 (2008/12/20)

Within the class of (4-pyridinyl)vinylpyridines developed by Abbott laboratories as potent neuronal nicotinic acetylcholine receptor ligands, p-PVP-MEMA ({(R)-2-[6-chloro-5-((E)-2-pyridin-4-ylvinyl)pyridin-3-yloxy]-1- methylethyl}methylamine) is the lead compound of a novel series that do not display the traditional nicotinic-like pyrrole-ring but still possessing high subnanomolar affinity (Ki 0.077 nm?displacement of [ 3H](?)cytisine from whole rat brain synaptic membranes). In the present study, p-PVP-MEMA and its nor-derivative ({(R)-2-[6-chloro-5-((E)-2- pyridin-4-ylvinyl)pyridin-3-yloxy]-1-methylethyl}methylamine) as precursor for labelling with the short-lived positron-emitter carbon-11 (T1/2 20.4 min) were synthesized in 10 chemical steps from 2-hydroxy-5-nitropyridine and Boc-d-alanine. N-Alkylation of nor-p-PVP-MEMA with [11C]methyl iodide afforded [11C]p-PVP-MEMA (>98% radiochemically pure, specific activity of 86.4 GBq ?mol?1) in 2% (non-decay corrected and non-optimized) radiochemical yield, in 34 min (including HPLC purification and formulation). Preliminary positron emission tomography (PET) results obtained in a Papio hamadryas baboon showed that [11C]p-PVP-MEMA is not a suitable PET-radioligand. CSIRO 2008.

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

-

, (2008/06/13)

Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 444902-32-3